热门资讯> 正文
ARCA biopharma to Distribute Special Dividend Conditional on Shareholder Approval of Oruka Therapeutics Merger
2024-08-17 04:59
04:59 PM EDT, 08/16/2024 (MT Newswires) -- ARCA biopharma (ABIO) said late Friday that it will distribute a special dividend estimated to be $1.59 per share, subject to approval of the proposed merger with Oruka Therapeutics by ARCA shareholders.
The exact amount of the dividend will be based on the merger agreement and ARCA's estimate of how much its net cash exceeds $5 million before the merger closes, the company said.
The dividend is payable on Aug. 28 to shareholders of record on Aug. 26, the company said.
The proposed merger is expected to close on Aug. 29.
Shares of ARCA were up about 13% in recent after-hours activity.
Price: 3.3200, Change: +0.37, Percent Change: +12.54
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
